Table 1.
Major Classes of Medications Used in the Treatment of JIA
Class of Medication | Description | Examples |
---|---|---|
Glucocorticoids [80] | -Potent anti-inflammatories-Administered by
PO, IV, or IA routes -Used short-term/as bridging therapy -IA can be definitive treatment of oligo-JIA |
-Prednisone-Prednisolone -Methylprednisolone -Triamcinolone (hex)acetonide |
Non-Steroidal Anti-Inflammatory Drugs [23] | -Oral medications used as monotherapy in mild
disease -Often taken in conjunction with other medications |
-Naproxen -Meloxicam -Indomethacin -Celecoxib |
Conventional Synthetic DMARDs [23] [81] | -Widely used class of JIA
medications -Slow-acting -Toxicity often associated with intolerance |
-Methotrexate -Sulfasalazine -Leflunomide |
Biologic DMARDs [82] | -Targeted parenteral drugs used to treat patients with more severe or refractory JIA | -Etanercept -Adalimumab -Tocilizumab -Abatacept |
Targeted Synthetic DMARDs [83] [84] [85] | -Newer class of targeted, oral
drugs -Little known about efficacy and safety in JIA to date |
-Tofacitinib -Baricitinib |
DMARD disease-modifying anti-rheumatic drug, IA intraarticular, IV intravenous, JIA juvenile idiopathic arthritis, oligo-JIA oligoarticular juvenile idiopathic arthritis, PO oral